Uterine Fibroid Treatments Will See Outpatient Payment Boost In 2008
This article was originally published in The Gray Sheet
Executive Summary
Reimbursement for uterine fibroid treatments get a boost in CMS' 2008 hospital outpatient 1rule, fueling industry expectations for increased market penetration by device-based alternatives to surgery